Jabodon PT Co’s UnitedHealth UNH Stock Holding History

Jabodon PT Co’s Portfolio UNH Stock Details UNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-4,995	Closed	-$1.24M	–	27
2019 Q1	$1.24M	Buy	+4,995	New	+$1.27M	1.04%	23

Other funds holding UNH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jabodon PT Co's UNH Position: Q2 2019 in Review

Jabodon PT Co sold out of UnitedHealth (UNH) in Q2 2019, closing a stake of 4,995 shares — an estimated $1.24M sold.

Jabodon PT Co first reported a position in UNH in Q1 2019 and held it in 1 quarter. The position peaked at $1.24M in Q1 2019. 1,965 funds tracked by Wall St. Rank hold UNH as of Q2 2019.

Jabodon PT Co reported no remaining UnitedHealth position as of Q2 2019 after selling out during the quarter.
Jabodon PT Co sold 4,995 UnitedHealth shares in Q2 2019, an estimated $1.24M.
Jabodon PT Co first reported a position in UnitedHealth in Q1 2019 and held it in 1 quarter.
Jabodon PT Co's UnitedHealth position peaked at $1.24M in Q1 2019.
1,965 funds tracked by Wall St. Rank held UnitedHealth as of Q2 2019.

Based on Jabodon PT Co's 13F filing for Q2 2019, filed 7 Aug 2019.